Acta Neuropathologica

, Volume 135, Issue 1, pp 153–154 | Cite as

Regional levels of physiological α-synuclein are directly associated with Lewy body pathology

  • Daniel ErskineEmail author
  • Lina Patterson
  • Athanasios Alexandris
  • Peter S. Hanson
  • Ian G. McKeith
  • Johannes Attems
  • Christopher M. Morris


Lewy body (LB) pathology has been described as progressing through the brain in a stereotyped sequence, suggesting it may spread in a trans-synaptic manner similar to prion protein [1]. A recent report demonstrated α-synuclein pathology in the deep cerebellar nuclei of LB disease cases [4]. However, the cerebellar cortex is strongly connected with early predilection sites in the brainstem yet had virtually no α-synuclein pathology, indicating anatomical connectivity is not the sole determinant of vulnerability and cell- or region-autonomous factors may influence its development [5]. A previous study in wild-type mice suggested an association between regional expression levels of physiological α-synuclein and vulnerability to LB pathology [6]. However, no study has yet compared the expression of physiological α-synuclein across human brain regions and evaluated its relationship to α-synuclein pathology. Therefore, we sought to quantify regional expression levels of...



Tissue for this study was provided by Newcastle Brain Tissue Resource, which is funded in part by a grant from the UK Medical Research Council and by Brains for Dementia Research, a joint venture between Alzheimer’s Society and Alzheimer’s Research UK. D.E. is funded by Alzheimer’s Research UK.

Compliance with ethical standards

Conflict of interest

The authors declare they have no conflict of interest.

Ethical approval

Ethical approval was granted by Newcastle University Ethics Board and the Joint Ethics Committee of Newcastle and North Tyneside Health Authority (ref: 08/H0906/136).

Supplementary material

401_2017_1787_MOESM1_ESM.pdf (694 kb)
Supplementary material 1 (PDF 693 kb)


  1. 1.
    Brundin P, Melki R, Kopito R (2010) Prion-like transmission of protein aggregates in neurodegenerative diseases. Nat Rev Mol Cell Biol 11:301–307. CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Masuda-Suzukake M, Nonaka T, Hosokawa M, Kubo M, Shimozawa A et al (2014) Pathological alpha-synuclein propagates through neural networks. Acta Neuropathol Commun 2:88. CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Mittal S, Bjornevik K, Im DS, Flierl A, Dong X et al (2017) beta2-Adrenoreceptor is a regulator of the alpha-synuclein gene driving risk of Parkinson’s disease. Science (New York, NY) 357:891–898. CrossRefGoogle Scholar
  4. 4.
    Seidel K, Bouzrou M, Heidemann N, Kruger R, Schols L et al (2017) Involvement of the cerebellum in Parkinson disease and dementia with Lewy bodies. Ann Neurol 81:898–903. CrossRefPubMedGoogle Scholar
  5. 5.
    Surmeier DJ, Obeso JA, Halliday GM (2017) Selective neuronal vulnerability in Parkinson disease. Nat Rev Neurosci 18:101–113. CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Taguchi K, Watanabe Y, Tsujimura A, Tanaka M (2016) Brain region-dependent differential expression of alpha-synuclein. J Comp Neurol 524:1236–1258. CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2017

Authors and Affiliations

  1. 1.Institute of NeuroscienceNewcastle UniversityNewcastle upon TyneUK
  2. 2.Institute of Cellular MedicineNewcastle UniversityNewcastle upon TyneUK

Personalised recommendations